Androgens and benign prostatic hyperplasia

European Urology, Supplements

Volumn 5, Issue 4 SPEC. ISS., 2006, Pages 410-417

  Mirone, Vincenzo ^a,d   Fusco, Ferdinando ^a   Verze, Paolo ^a   Schulman, Claude ^b   Debruyne, Frans ^c   Imbimbo, Ciro ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ERASME HOSPITAL   (Belgium)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

Androgens; Apoptotic mechanism; Benign prostatic hyperplasia; Dihydrotestosterone; Growth factor

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GROWTH INHIBITOR; GROWTH PROMOTOR; ISOENZYME; STEROID 5ALPHA REDUCTASE;

ADRENAL GLAND; APOPTOSIS; BLADDER NECK STENOSIS; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL TYPE; GENE EXPRESSION; HOMEOSTASIS; HORMONE SYNTHESIS; HORMONE TRANSPORT; HUMAN; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; REVIEW; TESTIS; URETHRA;

EID: 33644776600     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2006.02.004     Document Type: Article

References (52)

1. C. Carson III, and R. Rittmaster The role of dihydrotestosterone in benign prostatic hyperplasia Urology 61 2003 2 7
2. J.D. Wilson Role of dihydrotestosterone in androgen action Prostate 6 1996 88 92
3. K. Griffiths, A.T. Cockett, and D. Coffey Regulation of prostate growth L. Denis K. Grriffiths S. Khoury The 4th International Consultation on Benign Prostatic Hyperplasia 1998 Health Publications Plymouth, United Kingdom 83 128
4. J.T. Grayhack, C. Lee, and W. Brand The effect of testicular irradiation on established BPH in the dog: evidence of a non-steroidal testicular factor for BPH maintenance J Urol 134 1985 1276 1281
5. D.P. DeKlerk, D.S. Coffey, and L.L. Ewing Comparison of spontaneous and experimentally induced canine prostatic hyperplasia J Clin Invest 64 1979 842 849
6. C. Lee Physiology of castration-induced regression in rat prostate Prog Clin Biol Res 75A 1981 145 159
7. M. Krieg, R. Nass, and S. Tunn Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate J Clin Endocrinol Metab 77 1993 375 381
8. R.O. Roberts, D.J. Jacobson, T. Rhodes, G.G. Klee, M.M. Leiber, and S.J. Jacobsen Serum sex hormones and measures of benign prostatic hyperplasia Prostate 61 2004 124 131
9. Prings GS. Developmental estrogenization of the prostate gland. In: Naz RK editor. Prostate: basic and clinical aspects. Boca Raton, FL: CRC Press; p. 247-63.
10. F.S. vom Saal, B.G. Timms, and M.M. Montano Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses Proc Natl Acad Sci USA 94 1997 2056 2061
11. J.H. Krege, J.B. Hodgin, and J.F. Couse Generation and reproductive phenotypes of mice lacking estrogen receptor beta Proc Natl Acad Sci USA 95 1998 15677 15682
12. E. Shapiro, H. Huang, R.J. Masch, D.E. McFadden, E.L. Wilson, and X.R. Wu Immunolocalization of estrogen receptor alpha and beta in human fetal prostate J Urol 174 2005 2051 2053
13. N. Kyprianou, and J.T. Isaacs Quantal relationship between prostatic dihydrotestosterone and prostatic cell content: critical threshold concept Prostate 11 1987 41 50
14. W.L. McKeehan Growth factor receptors and prostate cell growth Cancer Surv 11 1991 165 175
15. C. Lee Role of androgen in prostate growth and regression: stromal-epithelial interaction Prostate Suppl 6 1996 52 56
16. W.D. Steers 5α-reductase activity in the prostate Urology 58 2001 17 24
17. G. Bartsch, R.S. Rittmaster, and H. Klocker Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia World J Urol 19 2002 413 425
18. T. Shirakawa, H. Okada, and B. Acharya Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue Prostate 58 2004 33 40
19. P.C. Walsh, J.D. Madden, and M.J. Harrod Familial incomplete male pseudohermaphroditism, type 2: decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias N Engl J Med 291 1974 944 949
20. J.A. Schalken The androgen cascade in aging man: blessing or curse? Eur Urol Suppl 2 8 2003 8 12
21. G. Andriole, N. Bruchovsky, and L.W. Chung Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia J Urol 172 2004 1399 1403
22. B. Chatterjee The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer Mol Cell Biochem 253 2003 89 101
23. J.A. Schalken, and G. van Leenders Cellular and molecular biology of the prostate: stem cell biology Urology 62 2003 11 20
24. J.A. Schalken Androgen receptor mediated growth of prostate (cancer) Eur Urol Suppl 4 8 2005 4 11
25. S.R. Denmeade, X.S. Lin, and J.T. Isaacs Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer Prostate 28 1996 251 265
26. J.H. Mydlo, J. Michaeli, W.D.W. Heston, and W.R. Fair Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma Prostate 13 1988 241 247
27. M.T. Story Regulation of prostate growth by fibroblast growth factors World J Urol 13 1995 297 305
28. E.R. Sherwood, C.J. Fong, C. Lee, and J.M. Kozlowski Basic fibroblast growth factor: a potential mediator of the stromal growth in the human prostate Endocrinology 130 1992 2955 2963
29. R.W. Furlanetto, J.N. Dicarlo, and C. Wisehart The type II insulin-like growth factor receptor does not mediate deoxyribonucleic synthesis in human fibroblasts J Clin Endocrinol Metab 64 1987 1142 1149
30. J.I. Jones, and D.R. Clemmons Insulin-like growth factors and their binding proteins: biological actions Endocr Rev 16 1995 3 34
31. P. Cohen, D.M. Peehl, G. Lamson, and R.G. Rosenfels Insulin like growth factors (IGFs), IGF receptors, and IGF binding proteins in primary cultures of prostate epithelial cells J Clin Endocrinol Metab 73 1991 401 407
32. A.M. Colao, O. Marzullo, and S. Speizia Effect of growth hormone (GH) and insulin-like growth factor-I on prostatic disease: an ultrasonographic and endocrine study in acromegaly, GH deficiency and healthy subjects J Clin Endocrinol Metab 84 1999 1986 1991
33. S. Monti, F. Di Silverio, and R. Iraci Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens J Clin Endocrinol Metab 86 2001 1700 1706
34. H. Fuse, M. Sakamoto, M. Okumura, and T. Katayama EGF contents in seminal plasma as a marker of prostatic function Arch Androl 29 1992 79 85
35. C.J. Fong, E.R. Sherwood, and G.M. Abu-Jawdeh Reconstituted basement membrane promotes morphological and functional differentiation of primary human prostatic epithelial cells Prostate 19 1991 221 235
36. J.A. Nemeth, J.A. Sensibar, R.R. White, D.J. Zelner, I.Y. Kim, and C. Lee Prostatic ductal system in rats: tissue specific expression and regional variation in stromal distribution of transforming growth factor β1 Prostate 33 1997 64 71
37. P. Martokainen, N. Kyprianou, and J.T. Isaacs Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells Endocrinology 127 1990 2963 2968
38. D. Danielpour Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a luminal phenotype: regulation by glucocorticoid, insulin-like growth factor-I and transforming growth factor-beta J Cell Sci 112 1999 169 179
39. A. Kassen, D.M. Sutkowski, H.J. Ahn, J.A. Sensibar, J.M. Kozlowski, and C. Lee Stromal cell of human prostate: initial isolation and characterization Prostate 28 1996 89 97
40. D.L. Peehl, and R.G. Sellers Induction of smooth muscle cell phenotypes in cultured human prostatic stromal cells Exp Cell Res 232 1997 208 215
41. G.H. Muir, A. Butta, and R.J. Shearer Induction of transforming growth factor beta in hormonally treated human prostate cancer Br J Cancer 69 1994 130 134
42. R.E. Deering, S.A. Bigler, M. Brown, and M.K. Brawer Microvascularity in benign prostatic hyperplasia Prostate 26 1995 111 115
43. A. Shabisgh, N. Tanji, and V. D'Agati Early effects of castration on the vascular system of the rat ventral prostate gland Endocrinology 140 1999 1920 1926
44. P.W. Kohnen, and G.W. Drach Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study J Urol 121 1975 755 760
45. G. Steiner, A. Gesse, G. Kramer, A. Schollhammer, O. Forster, and M. Marberger Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia J Urol 151 1994 480 484
46. S. Blotnick, G.E. People, M.R. Freeman, T.J. Eberlein, and M. Klagsbrun T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblast: differential production and release by CD4+ and CD8+ T cells Proc Natl Acad Sci USA 91 1994 2890 2894
47. G. Bartsch, H.R. Muller, M. Oberholzer, and H.P. Rohr Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia J Urol 122 1979 487 491
48. M. Cardillo, G. Berchem, and M.A. Tarkington Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation J Urol 158 1997 212 216
49. G. Untergasser, S. Madersbacher, and P. Berger Benign prostatic hyperplasia: age-related tissue-remodeling Exp Gerontol 40 2005 121 128
50. S. Monti, F. Di Silverio, and V. Toscano Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH) J Androl 19 1998 428 433
51. F. Comhaire, and A. Mahmoud Preventing diseases of the prostate in the elderly using hormones and nutriceuticals Aging Male 7 2004 155 169
52. ®): a 5α-reductase types 1 and II inhibitor - new evidence in a coculture model of BPH Prostate 40 1999 232 241